SCHEDULE: Deep Track Capital Discloses 7.13% Stake in ZURA Bio
Beneficial Ownership Disclosure
Deep Track Capital and affiliates have disclosed a 7.13% beneficial ownership stake in ZURA Bio Ltd, totaling 4,616,514 Class A Ordinary Shares.
Summary
- Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively reported beneficial ownership of 4,616,514 Class A Ordinary Shares of ZURA Bio Ltd.
- This ownership represents 7.13% of ZURA Bio Ltd.'s Class A Ordinary Shares.
- The ownership calculation is based on 64,763,950 shares, which includes 61,874,998 Ordinary Shares outstanding as of May 5, 2025, and 2,882,952 Pre-Funded Warrants exercisable into common shares.
- The reporting persons share both voting and dispositive power over all 4,616,514 shares.
- The Pre-Funded Warrants are subject to a 9.99% maximum exercise limitation, preventing the holder from exceeding this percentage of outstanding shares immediately after giving effect to such exercise.
- The filing states that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: This is a routine disclosure of beneficial ownership by an institutional investor, indicating a significant but passive stake in the company. It does not contain performance data or forward-looking statements to assess sentiment.
Future Outlook
The filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
Deep Track Capital is an investment adviser specializing in biotechnology, indicating a focused investment in the biotech sector. This filing provides transparency on significant institutional holdings within the industry.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling confidence from a specialized biotech investor.
Key Dates
| Date | Description |
|---|---|
| 05/05/2025 | Date of 61,874,998 Ordinary Shares outstanding according to ZURA Bio Ltd.'s 10-Q filing. |
| 05/08/2025 | Date ZURA Bio Ltd.'s 10-Q was filed with the SEC. |
| 06/30/2025 | Date of event which requires filing of this statement. |
| 08/14/2025 | Date of signing of the Schedule 13G Amendment No. 3. |
Keywords
ZURA Bio Ltd, Deep Track Capital, Deep Track Biotechnology Master Fund, David Kroin, Schedule 13G, beneficial ownership, Class A Ordinary Shares, SEC filing, institutional ownership, biotech investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.